RenovoRx Appoints James Ahlers as Chief Financial Officer
19.07.2022 - RenovoRx, Inc. (Nasdaq: RNXT), a biopharmaceutical company and innovator in targeted cancer therapy, today is announcing the appointment of James Ahlers as Chief Financial Officer (CFO), effective July 15, 2022, and the addition of Ronald B. Kocak ... Seite 1
Source: wallstreet-online.de